Aurobindo Pharma Approves Internal Reorganization of Russian Subsidiary for INR 29 Crore
Aurobindo Pharma Ltd · Others (Uncategorized) · 05 Nov 2026, 2:04 am
Aurobindo Pharma Approves Internal Reorganization of Russian Subsidiary for INR 29 Crore Aurobindo Pharma approved the transfer of 100% ownership in its Russian step-down subsidiary, Auro Pharma LLC, from Auro Active Pharma Private Limited to Auropharm Overseas Limited, both wholly owned subsidiaries. Undertaken at an arm’s length cash consideration of ~INR 29 crore, the transaction is an internal reorganization to streamline Russian holdings. Auro Pharma LLC, incorporated on 24th Jul'23 for manufacturing and marketing pharmaceuticals, reported nil turnover across FY24–FY26. The acquisition requires no regulatory approvals and is slated for completion within 60–90 days.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. · 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. · 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". · 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. · 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. · 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. · 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. · 05 Nov 2026
- Approved the proposal of Merger of two wholly owned subsidiaries of the Company. · 05 Nov 2026
